E. M. S. Pérez et al. / Carbohydrate Research 345 (2010) 23–32
29
(CH3), 2112 (N3), 1758 (C@O), 1238 (C–O–C), 1104, 1058, 1041 (C–
O) cmꢁ1 1H NMR (400 MHz, Me2CO-d6) d 5.02 (t, 1H, J3,4 = J2,3
2H, H-arom), 6.92 (d, 2H, J 8.8 Hz, H-arom), 5.38 (t, 1H, J3,4 = J2,3
9.6 Hz, H-3), 5.12 (t, 1H, J3,4 = J4,5 9.8 Hz, H-4), 5.04 (d, 1H, J1,2
;
0
9.8 Hz, H-3), 4.93 (t, 1H, J4,5 = J3,4 9.6 Hz, H-4), 4.77 (d, 1H, J1,2
8.3 Hz, H-1), 4.37 (dd, 1H, J5,6 5.0 Hz, J6,6 12.4 Hz, H-6), 4.19 (dd,
1H, J5,6 2.4 Hz, J6,6 12.4 Hz, H-60), 3.92 (ddd, 1H, J4,5 10.1 Hz, J5,6
0
0
0
8.8 Hz, H-1), 4.25 (dd, 1H, J5,6 5.2 Hz, J6,6 12.4 Hz, H-6), 4.10 (dd,
1H, J5,6 2.2 Hz, J6,6 12.2 Hz, H-60), 3.96 (ddd, 1H, J4,5 10.0 Hz, J5,6
4.8 Hz, J5,6 2.4 Hz, H-5), 3.85 (s, 3H, OCH3), 3.25 (t, 1H, J1,2 ꢃ J2,3
0
0
0
0
4.7 Hz, J5,6 2.2 Hz, H-5), 2.71 (t, 1H, J1,2 ꢃ J2,3 9.4 Hz, H-2), 2.01,
9.2 Hz, H-2), 2.13, 2.04, 1.88 (s, 3 ꢄ 3H, CH3). 13C NMR (100 MHz,
CDCl3): 170.65, 169.75, 169.53 (C@O), 164.80 (N@C), 162.29,
130.32, 128.07, 114.03 (C-arom), 89.56 (C-1), 73.94 (C-2), 73.69
(C-5), 73.12 (C-3), 67.96 (C-4), 61.96 (C-6), 55.38 (OCH3), 20.74,
20.62, 20.47 (CH3).
2.00, 1.98 (s, 3 ꢄ 3H, CH3); 13C NMR (100 MHz, Me2CO-d6) d
170.87, 170.26, 169.83 (4C@O), 92.44 (C-1), 56.95 (C-2), 75.82
(C-5), 74.54 (C-3), 65.05 (C-4), 62.87 (C-6), 20.80, 20.66, 20.55
(CH3); 1H NMR (400 MHz, CDCl3) d 5.03 (t, 1H, J3,4 = J2,3 9.4 Hz, H-
3), 4.96 (t, 1H, J4,5 = J3,4 9.6 Hz, H-4), 4.54 (d, 1H, J1,2 8.8 Hz, H-1),
0
4.30 (dd, 1H, J5,6 4.8 Hz, J6,6 12.4 Hz, H-6), 4.14 (dd, 1H, J5,6
4.6. 3,4,6-Tri-O-acetyl-2-deoxy-2-(2-hydroxybenzylidenami-
no)-b-D-glucopyranosylazide (13)
´
2.4 Hz, J6,6 12.4 Hz, H-60), 3.78 (ddd, 1H, J4,5 9.6 Hz, J5,6 4.8 Hz,
0
0
J5,6 2.4 Hz, H-5), 2.82 (t, 1H, J1,2 ꢃ J2,3 9.4 Hz, H-2), 2.10, 2.08,
2.03 (s, 3 ꢄ 3H, CH3). 13C NMR (100 MHz, CDCl3): 170.64, 169.62
(3C@O), 91.89 (C-1), 75.17 (C-5), 73.94 (C-3), 68.30 (C-4), 61.98
(C-6), 55.82 (C-2), 20.75, 20.73, 20.62 (CH3).
This compound was synthesized following the recipe for com-
pound 12 (0.024 g, 56%); Mp 88–90 °C; [Lit.35 mp 95 °C]; ½a D24
ꢂ
24
578
24
546
24
436
ꢁ6.0; ½
aꢂ
ꢁ6.4; ½
aꢂ
ꢁ7.4; ½
a
ꢂ
ꢁ15.6 (c 0.5, CHCl3); IR (KBr)
mmax 2118 (N3), 1753, 1742 (C@O), 1629 (C@N), 1578 (arom),
1279, 1239 (C–O–C, ester), 1040 cmꢁ1 (C–O); 1H NMR (400 MHz,
CDCl3) d 12.09 (s, 1H, OH-arom), 8.33 (s, 1H, N@CH), 7.37 (t, 1H,
H-arom), 7.31 (d, 1H, H-arom), 6.97 (t, 1H, H-arom), 6.92 (t, 1H,
H-arom), 5.42 (t, 1H, J3,4 = J2,3 9.8 Hz, H-3), 5.13 (t, 1H, J3,4 = J4,5
9.8 Hz, H-4), 5.00 (d, 1H, J1,2 8.4 Hz, H-1), 4.37 (dd, 1H, J5,6 4.8 Hz,
4.3. 3,4,6-Tri-O-acetyl-2-deoxy-2-isopropylidenamino-b-d-
glucopyranosylazide (3)
A solution of 10 (0.50 g, 1.51 mmol) in dry acetone (25.0 mL) was
kept for 40 h at room temperature. Then, the solvent was evaporated
and the process was repeated, another solution in dry acetone
(25.0 mL) was prepared and was kept for 40 h. After this, the solvent
was evaporated and the residue was dried in vacuum (0.54 g, 97%);
J6,6 12.4 Hz, H-6), 4.19 (dd, 1H, J5,6 2.4 Hz, J6,6 12.4 Hz, H-60),
0
0
0
0
3.95 (ddd, 1H, J4,5 10.0 Hz, J5,6 4.8 Hz, J5,6 1.6 Hz, H-5), 3.26 (t,
1H, J1,2 ꢃ J2,3 9.0 Hz, H-2), 2.12, 2.05, 1.92 (s, 3 ꢄ 3H, CH3). 13C
NMR (100 MHz, CDCl3): 170.72, 170.59, 169.68, 169.50 (C@O),
169.41 (N@C), 160.86, 133.50, 132.17, 119.04, 118.07, 117.28 (C-
arom), 89.13 (C-1), 74.00 (C-2), 73.06 (C-5), 72.48 (C-3), 67.78 (C-
4), 61.81 (C-6), 20.83, 20.71, 20.59, 20.44 (CH3).
25
578
25
546
25
436
Mp 137–139 °C; ½a D25
ꢂ
ꢁ51.2; ½
aꢂ
ꢁ66.6; ½
aꢂ
ꢁ63.2; ½
a
ꢂ
ꢁ47.8 (c
0.5, CHCl3); IR (KBr) mmax 2114 (N3, azide), 1747 (C@O, ester), 1668
(C@N), 1240 (C–O–C, ester), 1106, 1065, 1032 cmꢁ1 (C–O); 1H
NMR (400 MHz, CDCl3) d 5.26 (t, 1H, J3,4 = J2,3 9.6 Hz, H-3), 5.11 (t,
1H, J3,4 = J4,5 9.8 Hz, H-4), 4.93 (d, 1H, J1,2 8.4 Hz, H-1), 4.37 (dd, 1H,
0
0
0
J5,6 4.8 Hz, J6,6 12.4 Hz, H-6), 4.18 (dd, 1H, J5,6 2.0 Hz, J6,6 12.4 Hz,
4.7. 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-b-D-glucopyranose
(18)
H-60), 3.88 (ddd, 1H, J4,5 10.0 Hz, J5,6 4.8 Hz, J5,6 2.0 Hz, H-5), 3.57
0
(t, 1H, J1,2 8.8 Hz, J2,3 9.6 Hz, H-2), 2.12, 2.05, 1.97, 1.94 (s, 5 ꢄ 3H,
CH3). 13C NMR (100 MHz, CDCl3): 172.87 (C@N), 170.87, 170.26,
169.83 (4C@O), 90.22 (C-1), 73.91 (C-3), 73.79 (C-5), 68.05 (C-4),
64.14 (C-2), 61.87 (C-6), 20.65, 20.53 (CH3). Anal Calcd for
C15H22N4O7: C, 48.64; H, 5.99; N, 15.13. Found: C, 48.33; H, 6.05;
N, 15.01. HRMS-FAB calcd for C15H22N4O7[M+Na]+: 393.1386;
found: 393.1397.
To compound 16 (1.0 g, 2.61 mmol) were added water (10 mL)
and CH2Cl2 and the mixture was treated with NaHCO3 (0.2 g). Then,
the aqueous phase was extracted three times more with 10, 5, and
3 mL of CH2Cl2. Finally, it was dried (MgSO4) and evaporated to
dryness (0.6 g, 66%); mp 141 °C [Lit.17 mp 143 °C, [
a]D +25.9° (chlo-
25
25
25
roform)]; ½a 2D5
ꢂ
+20.0; ½
a
m
ꢂ
+20.8; ½
aꢂ
+24.0; ½
aꢂ
+42.2 (c 0.5,
436
578
546
dry acetone); IR (KBr)
3000–2597 NH3þ, 2920 (OCH3), 1755,
max
4.4. Spectroscopic data of 3,4,6-tri-O-acetyl-2-deoxy-2-hexadeu-
1738 (C@O), 1242, 1212 (C–O–C, ester), 1072, 1031, 1016 (C–O)
terio-isopropyliden-amino-b-D-glucopyranosylazide (11)
cmꢁ1
;
1H NMR (400 MHz, CDCl3) d 5.47 (d, 1H, J1,2 8,4 Hz, H-1),
0
5.04 (m, 2H, H-3 and H-4), 4.34 (dd, 1H, J6,6 12.4 Hz, J5,6 4.4 Hz,
1H NMR (400 MHz, Me2CO-d6) d 5.21 (t, 1H, J3,4 = J2,3 9.8 Hz, H-3),
5.03 (t, 1H, J3,4 = J4,5 8.6 Hz, H-4), 5.06 (d, 1H, J1,2 7.2 Hz, H-1), 4.29
H-6), 4.09 (dd, 1H, J6,6 12.4 Hz, J5,6 2.0 Hz, H-60), 3.82 (ddd, 1H,
0
0
0
J4,5 9.6 Hz, J5,6 4.4 Hz, J5,6 2.5 Hz, H-5), 3.04 (t, 1H, J1,2 8,4 Hz, H-
2), 2.19, 2.11, 2.09, 2.04 (4 ꢄ 3H, s, CH3), 1.22 (2H, br s, NH2); 13C
NMR (100 MHz, CDCl3) d 170.66, 169.63, 169.69, 169.20 (4C@O),
95.26 (C-1), 75.11 (C-5), 72.71 (C-3), 68.22 (C-4), 61.77 (C-6),
55.06 (C-2), 20.97, 20.78, 20.65 (CH3); 1H NMR (400 MHz,
Me2CO-d6) d 5.59 (d, 1H, J1,2 8.4 Hz, H-1), 5.10 (t, 1H, J2,3 = J3,4
9.8 Hz, H-3), 4.96 (t, 1H, J3,4 = J4,5 9.6 Hz, H-4), 4.24 (dd, 1H, J5,6
0
0
0
(dd, 1H, J5,6 5.2 Hz, J6,6 12.4 Hz, H-6), 4.14 (dd, 1H, J5,6 2.4 Hz, J6,6
12.4 Hz, H-60), 4.08 (ddd, 1H, J4,5 10.0 Hz, J5,6 5.4 Hz, J5,6 2.2 Hz, H-
5), 3.59 (t, 1H, J1,2 8.6 Hz, J2,3 9.8 Hz, H-2), 2.02, 1.97, 1.91 (s,
5 ꢄ 3H, CH3). 13C NMR (100 MHz, Me2CO-d6): 172.48 (C@N),
170.80. 170.29, 169.83 (4C@O), 90.80 (C-1), 74.54 (C-3), 74.54 (C-
5), 69.24 (C-4), 65.05 (C-2), 62.87 (C-6), 20.65, 20.53 (CH3).
0
0
0
4.8 Hz, J6,6 12.4 Hz, H-6), 4.06 (dd, 1H, J5,6 2.4 Hz, J6,6 12.4 Hz, H-
0
4.5. 3,4,6-Tri-O-acetyl-2-deoxy-2-(4-methoxybenzylidenami-
60), 3.97 (ddd, 1H, J4,5 10.0 Hz, J5,6 2.4 Hz, J5,6 4.8 Hz, H-5), 2.90
no)-b-
D
-glucopyranosyl-azide (12)
(dd, 1H, J1,2 8.6 Hz, J2,3 10.4 Hz, H-2), 2.12, 2.02, 2.01, 1.99 (s,
4 ꢄ 3H, CH3), 1.57 (br s, 1H, NH2) ppm; 13C NMR (100 MHz,
Me2CO-d6): 169.87, 169.81, 169.27, 168.86 (4C@O), 95.23 (C-1),
74.86 (C-5), 72.28 (C-3), 68.59 (C-4), 61.88 (C-6), 55.50 (C-2),
19.95, 19.92, 19.80, 19.76 (CH3).
To a solution of 10 (0.033 g, 0.1 mmol) in MeOH (1 mL) was
added a solution of 4-methoxybenzaldehyde (0.012 mL, 0.1 mmol)
in MeOH (1 mL). The solution was stirred until a solid appeared,
then was maintained in the refrigerator for a few hours. The solid
was filtered, washed with a cold methanol and the product was
recrystallized from MeOH (0.04 g, 90%). Mp 134–136 °C; [Lit.35
4.8. 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-a-D-glucopyranose
(19)
mp 134 °C]; ½a 2D3
ꢂ
+34.0; ½
aꢂ
+36.8; ½
a
ꢂ
+44.0; ½
aꢂ
+109.4 (c
23
23
546
23
436
578
0.5, CHCl3); IR (KBr) mmax 2361 (N3), 1749 (C@O), 1639 (C@N),
1604, 1513 (arom), 1240 (C–O–C, ester), 1037 cmꢁ1 (C–O); 1H
NMR (400 MHz, CDCl3) d 8.16 (s, 1H, N@CH), 7.67 (d, J 8.8 Hz,
To compound 17 (1.0 g, 2.34 mmol) was added water (10 mL)
and CH2Cl2 (10 mL), the mixture was treated with NaHCO3
(0.2 g). Then, the organic phase was separated and the aqueous